is januvia a semaglutide vs. Ozempic for Diabetes Type 2: Important Differences and Potential Risks Merck diabetes drug gets CV

Your body has had time to adjust to the GLP-1 receptor activation, and the initial side effects, if you had any, have typically stabilized or resolved

Healthcare providers often rely on clinical judgment and existing guidelines to manage patients on these medications

E., Neuschwander-Tetri, B

S.LeeS.et al (2019)

He added that Novo Nordisks GLP-1 portfolio is backed by more than 50 robust clinical trials, 49 million patient-years of exposure, extensive real-world data, world-class rDNA manufacturing processes, state-of-the-art devices and delivery systems, and the highest safety standards. In 2025, the World Health Organization added semaglutide to its Essential Medicines List, recognising its critical role in tackling the global health burden